Screener
Viridian Therapeutics, Inc. VRDN Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s book value per share?
- Viridian Therapeutics, Inc. (VRDN) reported book value per share of $6.31 in Q2 2025.
- How has Viridian Therapeutics, Inc.'s book value per share changed year-over-year?
- Viridian Therapeutics, Inc.'s book value per share decreased by 23.8% year-over-year, from $8.29 to $6.31.
- What is the long-term trend for Viridian Therapeutics, Inc.'s book value per share?
- Over 3 years (2020 to 2023), Viridian Therapeutics, Inc.'s book value per share has grown at a -33.6% compound annual growth rate (CAGR), from $33.75 to $9.88.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Viridian Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude